{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:39:55Z","timestamp":1759451995787,"version":"build-2065373602"},"reference-count":33,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.vaccine.2020.06.028","type":"journal-article","created":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T18:07:15Z","timestamp":1592676435000},"page":"5154-5162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Economic evaluation and budget impact analysis of dengue vaccination following pre-vaccination serological screening in India"],"prefix":"10.1016","volume":"38","author":[{"given":"Yuvaraj","family":"Krishnamoorthy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Gilbert","family":"Majella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9599","key":"10.1016\/j.vaccine.2020.06.028_b0005","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/S0140-6736(07)61687-0","article-title":"Dengue","volume":"370","author":"Halstead","year":"2007","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2020.06.028_b0010","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.mjafi.2014.09.011","article-title":"Discovery of fifth serotype of dengue virus (DENV-5): a new public health dilemma in dengue control","volume":"71","author":"Mustafa","year":"2015","journal-title":"Med J Armed Forces India"},{"key":"10.1016\/j.vaccine.2020.06.028_b0015","unstructured":"World Health Organization. Dengue and Severe dengue. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dengue-and-severe-dengue [accessed December 13, 2019]."},{"issue":"7446","key":"10.1016\/j.vaccine.2020.06.028_b0020","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.vaccine.2020.06.028_b0025","article-title":"Dengue burden in India: recent trends and importance of climatic parameters","volume":"6","author":"Mutheneni","year":"2017","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.vaccine.2020.06.028_b0030","unstructured":"National Vector Borne Disease Control Programme. Dengue\/DHF situation in India. Available from: https:\/\/nvbdcp.gov.in\/index4.php?lang=1&level=0&linkid=431&lid=3715 [accessed December 13, 2019]."},{"issue":"6","key":"10.1016\/j.vaccine.2020.06.028_b0035","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.4269\/ajtmh.14-0002","article-title":"Economic and disease burden of dengue illness in India","volume":"91","author":"Chellaswamy","year":"2014","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2020.06.028_b0040","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1016\/j.ijid.2019.01.010","article-title":"Economic burden of dengue illness in India from 2013 to 2016: A systematic analysis","volume":"84S","author":"Hariharan","year":"2019","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.06.028_b0045","first-page":"457","article-title":"Dengue vaccine: WHO position paper\u2013September 2018","volume":"93","author":"World Health Organization","year":"2018","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2020.06.028_b0050","unstructured":"Delrieu I. Update on vaccine licensing and public sector programs and introduction strategies in early adopting Asia and Latin America countries. In: 66th annual meeting of the american society of tropical medicine & hygiene. Baltimore, MD, USA. Nov. 8; 2017."},{"issue":"11","key":"10.1016\/j.vaccine.2020.06.028_b0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002182","article-title":"The dengue vaccine dilemma: balancing the individual and population risks and benefits","volume":"13","author":"Deen","year":"2016","journal-title":"PLoS Med"},{"issue":"6303","key":"10.1016\/j.vaccine.2020.06.028_b0060","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1126\/science.aaf9590","article-title":"Benefits and risks of the Sanofi-Pasteur dengue vaccine: Modeling optimal deployment","volume":"353","author":"Ferguson","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2020.06.028_b0065","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S1473-3099(16)30168-2","article-title":"The risks behind Dengvaxia recommendation","volume":"16","author":"Aguiar","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2020.06.028_b0070","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.vaccine.2017.11.064","article-title":"Cost-effectiveness of dengue vaccination in ten endemic countries","volume":"36","author":"Zeng","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.06.028_b0075","unstructured":"Ministry of Health and Family Welfare. National Immunization Schedule (NIS) for Infants, Children and Pregnant Women. [cited 2019 Dec 13]. Available from: https:\/\/mohfw.gov.in\/sites\/default\/files\/245453521061489663873.pdf."},{"issue":"1","key":"10.1016\/j.vaccine.2020.06.028_b0080","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2334-6-13","article-title":"Enzyme-linked immunoassay for dengue virus IgM and IgG antibodies in serum and filter paper blood","volume":"6","author":"Tran","year":"2006","journal-title":"BMC Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2020.06.028_b0085","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S2214-109X(19)30250-5","article-title":"Burden of dengue infection in India, 2017: a cross-sectional population based serosurvey","volume":"7","author":"Murhekar","year":"2019","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2020.06.028_b0090","doi-asserted-by":"crossref","first-page":"165","DOI":"10.12688\/wellcomeopenres.15507.1","article-title":"Estimating the proportion of vaccine-induced hospitalized dengue cases among Dengvaxia vaccinees in the Philippines","volume":"4","author":"Flasche","year":"2019","journal-title":"Wellcome Open Res"},{"key":"10.1016\/j.vaccine.2020.06.028_b0095","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJMoa1506223","article-title":"Efficacy and long-term safety of a dengue vaccine in regions of endemic disease","volume":"373","author":"Hadinegoro","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2020.06.028_b0100","unstructured":"World Health Organization. Questions and Answers on Dengue Vaccines. Available from: https:\/\/www.who.int\/immunization\/research\/development\/dengue_q_and_a\/en\/ [accessed March 21, 2020]"},{"key":"10.1016\/j.vaccine.2020.06.028_b0105","unstructured":"World Health Organization. Reported estimates of TT2+ coverage. Available from: http:\/\/apps.who.int\/immunization_monitoring\/globalsummary\/timeseries\/tscoveragett2plus.html [accessed December 13, 2019]."},{"key":"10.1016\/j.vaccine.2020.06.028_b0110","unstructured":"Edejer TT-T. World Health Organization, editors. Making choices in health: WHO guide to cost-effectiveness analysis. Geneva: World Health Organization; 2003."},{"key":"10.1016\/j.vaccine.2020.06.028_b0115","unstructured":"World Bank. Official exchange rate (LCU per US$, period average). Available from: https:\/\/data.worldbank.org\/indicator\/PA.NUS.FCRF [accessed December 13, 2019]."},{"issue":"7","key":"10.1016\/j.vaccine.2020.06.028_b0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007482","article-title":"Model based assessment of public health impact and cost-effectiveness of dengue vaccination following screening for prior exposure","volume":"13","author":"Espa\u00f1a","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2020.06.028_b0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101114","article-title":"Costs of introducing and delivering HPV vaccines in low and lower middle income countries: inputs for GAVI policy on introduction grant support to countries","volume":"9","author":"Levin","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.06.028_b0130","first-page":"1","article-title":"Overcoming data limitations: design of a multi-component study for estimating the economic burden of dengue in India","volume":"35","author":"Halasa","year":"2011","journal-title":"Dengue Bull"},{"issue":"10159","key":"10.1016\/j.vaccine.2020.06.028_b0135","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"James","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2020.06.028_b0140","unstructured":"Ministry of Health and Family Welfare. Universal Immunization Programme Comprehensive Multi-Year Plan. Available from: https:\/\/nhm.gov.in\/New_Updates_2018\/NHM_Components\/Immunization\/Guildelines_for_immunization\/cMYP_2018-22_final_pdf [accessed December 13, 2019]."},{"key":"10.1016\/j.vaccine.2020.06.028_b0145","unstructured":"World Bank. GDP per capita (current US$). Available from: https:\/\/data.worldbank.org\/indicator\/NY.GDP.PCAP.CD [accessed December 13, 2019]."},{"key":"10.1016\/j.vaccine.2020.06.028_b0150","unstructured":"World Health Organization. Macroeconomics and health: an update: increasing investments in health outcomes for the poor: second consultation on macroeconomics and health 2003. Available from: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/68536\/WHO_SDE_CMH_03.1.pdf [accessed December 13, 2019]."},{"key":"10.1016\/j.vaccine.2020.06.028_b0155","article-title":"Cost effectiveness of dengue vaccination following pre-vaccination serological screening in Sri Lanka","volume":"1\u20139","author":"Perera","year":"2019","journal-title":"Int J Technol Assess Health Care"},{"issue":"37","key":"10.1016\/j.vaccine.2020.06.028_b0160","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1016\/j.vaccine.2013.06.036","article-title":"Dengue dynamics and vaccine cost-effectiveness in Brazil","volume":"31","author":"Durham","year":"2013","journal-title":"Vaccine"},{"issue":"50","key":"10.1016\/j.vaccine.2020.06.028_b0165","doi-asserted-by":"crossref","first-page":"7091","DOI":"10.1016\/j.vaccine.2015.09.053","article-title":"Next generation dengue vaccines: A review of the preclinical development pipeline","volume":"33","author":"Vannice","year":"2015","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2030801X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2030801X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:46:57Z","timestamp":1759402017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2030801X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":33,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0264410X2030801X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.06.028","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Economic evaluation and budget impact analysis of dengue vaccination following pre-vaccination serological screening in India","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.06.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}